Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Case

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
The Journal of Clinical Psychiatry|November 2, 2005
Olanzapine/fluoxetine combination for treatment-resistant depression: a controlled study of SSRI and nortriptyline resistanceRichard C Shelton, Douglas J Williamson, Sara A Corya, et al.
The New England Journal of Medicine|September 10, 2024
Insulin Efsitora versus Degludec in Type 2 Diabetes without Previous Insulin TreatmentCarol Wysham, Harpreet S Bajaj, Stefano Del Prato, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 5, 2015
Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patientsEric R Siemers, Karen L Sundell, Christopher Carlson, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 27, 2026
Evaluation of Overall Health State, Treatment Burden, and Satisfaction with Insulin Efsitora Alfa (Efsitora) vs. Daily Comparator in Adults with Type 2 Diabetes in the QWINT Clinical Trial ProgramEden Miller, Michael B Davidson, Harpreet S Bajaj, et al.
The New England Journal of Medicine|July 17, 2023
Trial of Solanezumab in Preclinical Alzheimer's DiseaseReisa A Sperling, Michael C Donohue, Rema Raman, et al.
The New England Journal of Medicine|January 25, 2018
Trial of Solanezumab for Mild Dementia Due to Alzheimer's DiseaseLawrence S Honig, Bruno Vellas, Michael Woodward, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
The Journal of Clinical Psychiatry|November 2, 2005
Olanzapine/fluoxetine combination for treatment-resistant depression: a controlled study of SSRI and nortriptyline resistanceRichard C Shelton, Douglas J Williamson, Sara A Corya, et al.
The New England Journal of Medicine|September 10, 2024
Insulin Efsitora versus Degludec in Type 2 Diabetes without Previous Insulin TreatmentCarol Wysham, Harpreet S Bajaj, Stefano Del Prato, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 5, 2015
Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patientsEric R Siemers, Karen L Sundell, Christopher Carlson, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 27, 2026
Evaluation of Overall Health State, Treatment Burden, and Satisfaction with Insulin Efsitora Alfa (Efsitora) vs. Daily Comparator in Adults with Type 2 Diabetes in the QWINT Clinical Trial ProgramEden Miller, Michael B Davidson, Harpreet S Bajaj, et al.
The New England Journal of Medicine|July 17, 2023
Trial of Solanezumab in Preclinical Alzheimer's DiseaseReisa A Sperling, Michael C Donohue, Rema Raman, et al.
The New England Journal of Medicine|January 25, 2018
Trial of Solanezumab for Mild Dementia Due to Alzheimer's DiseaseLawrence S Honig, Bruno Vellas, Michael Woodward, et al.
Pageof 4